China, Sept. 16 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Clinical Study of CD70-Targeted ImmunoPET/CT Imaging for Primary Tumor Target Volume Delineation in Nasopharyngeal Carcinoma'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600132568
Registration Time: 2026/09/15
Type: Observational study
Primary Sponsor: Jiangxi Cancer Hospital
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=342849
Published by HT Digital Content Services with permission from Health Daily Digest....